Treatments used for obsessive–compulsive disorder—An international perspective. Brakoulias, V., Starcevic, V., Albert, U., Arumugham, S., S., Bailey, B., E., Belloch, A., Borda, T., Dell'Osso, L., Elias, J., A., Falkenstein, M., J., Ferrao, Y., A., Fontenelle, L., F., Jelinek, L., Kalogeraki, L., Kay, B., Laurito, L., D., Lochner, C., Maina, G., Marazziti, D., Martin, A., Matsunaga, H., Miguel, E., C., Morgado, P., Mourikis, I., Pasquini, M., Rivera, R., P., Potluri, S., Reddy, J., Y., C., Riemann, B., C., Rosario, M., C., d., Shavitt, R., G., Stein, D., J., Viswasam, K., Wang, Z., & Fineberg, N., A. Human Psychopharmacology: Clinical and Experimental, 34(1):e2686, 8, 2019.
Treatments used for obsessive–compulsive disorder—An international perspective [link]Website  abstract   bibtex   
Objective The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.
@article{
 title = {Treatments used for obsessive–compulsive disorder—An international perspective},
 type = {article},
 year = {2019},
 identifiers = {[object Object]},
 keywords = {antipsychotics,benzodiazepines,cross-cultural study,obsessive–compulsive disorder,pharmacotherapy,selective serotonin reuptake inhibitors},
 pages = {e2686},
 volume = {34},
 websites = {https://onlinelibrary.wiley.com/doi/abs/10.1002/hup.2686,http://files/357/Brakoulias et al. - 2019 - Treatments used for obsessive–compulsive disorder—.pdf,http://files/356/hup.html},
 month = {8},
 day = {25},
 id = {fbeb508e-5cb0-359e-afe4-8ad687761189},
 created = {2020-09-17T09:27:49.367Z},
 file_attached = {false},
 profile_id = {20f87055-ac78-3c65-9cf5-216a3558d16a},
 group_id = {14ca8526-77d5-34fd-89de-e48cae5e6ee2},
 last_modified = {2020-09-17T09:27:49.367Z},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {true},
 hidden = {false},
 source_type = {JOUR},
 language = {en},
 notes = {e2686 HUP-18-0068.R1},
 private_publication = {false},
 abstract = {Objective The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.},
 bibtype = {article},
 author = {Brakoulias, Vlasios and Starcevic, Vladan and Albert, Umberto and Arumugham, Shyam Sundar and Bailey, Brenda E and Belloch, Amparo and Borda, Tania and Dell'Osso, Liliana and Elias, Jason A and Falkenstein, Martha J and Ferrao, Ygor A and Fontenelle, Leonardo F and Jelinek, Lena and Kalogeraki, Leto and Kay, Brian and Laurito, Luana D and Lochner, Christine and Maina, Giuseppe and Marazziti, Donatella and Martin, Andrew and Matsunaga, Hisato and Miguel, Euripedes C and Morgado, Pedro and Mourikis, Irakis and Pasquini, Massimo and Rivera, Rodrigo Perez and Potluri, Sriramya and Reddy, Janardhan Y C and Riemann, Brian C and Rosario, Maria Conceição do and Shavitt, Roseli G and Stein, Dan J and Viswasam, Kirupumani and Wang, Zhen and Fineberg, Naomi A},
 journal = {Human Psychopharmacology: Clinical and Experimental},
 number = {1}
}

Downloads: 0